Michael J. Fox Foundation

Type

Other

Status

Active

Location

New York, United States

Total investments

68

Average round size

10M

Portfolio companies

58

Rounds per year

2.83

Lead investments

19

Follow on index

0.15

Exits

13

Stages of investment
Grant
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareHealth DiagnosticsMedicalLife ScienceNeurosciencePharmaceuticalTherapeuticsBiopharma

Summary

In 2000 was created Michael J. Fox Foundation, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the New York.

Among the most successful fund investment fields, there are Health Diagnostics, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, Inflazome, Ceregene.

This organization was formed by Deborah Brooks.

The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2016. Considering the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Michael J. Fox Foundation works on 0 percentage points less the average amount of lead investments.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Michael J. Fox Foundation, startups are often financed by MPM Capital, Third Rock Ventures, Sofinnova Partners. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, Agentschap NL. In the next rounds fund is usually obtained by Seventure Partners, Janke Dittmer, INKEF Capital.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
68
Lead investments
19
Exits
13
Rounds per year
2.83
Follow on index
0.15
Investments by industry
  • Biotechnology (54)
  • Health Care (37)
  • Therapeutics (23)
  • Pharmaceutical (22)
  • Medical (15)
  • Show 28 more
Investments by region
  • Canada (2)
  • United States (39)
  • Germany (1)
  • Denmark (4)
  • Switzerland (6)
  • Show 7 more
Peak activity year
2022
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
76M
Group Appearance index
0.04
Avg. company exit year
2
Avg. multiplicator
2.49
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Sapiens Steering Brain Stimulation 28 Nov 2011 Health Care, Medical, Therapeutics, Simulation Early Stage Venture 11M Munich, Bavaria, Germany

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.